Status:
COMPLETED
Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Tine
St. Olavs Hospital
Conditions:
Asthma
Dermatitis, Atopic
Eligibility:
All Genders
30-36 years
Phase:
NA
Brief Summary
A probiotic (Lactobacillus rhamnosus GG) supplement to pregnant women the last four weeks of pregnancy and three months after birth is expected to give a 40% reduction in risk of atopic sensitisation ...
Detailed Description
To investigate how probiotics given to pregnant women during the last 4 weeks of pregnancy and the first 4 months after birth influence the establishment and composition of the gut microflora in child...
Eligibility Criteria
Inclusion
- All pregnant women understanding Norwegian language and who has signed an informed consent form, can be included.
- Inclusion must take place before week 36 in the pregnancy.
- The woman must plan to breast-feed the first 4 months after birth.
- She must live in Trondheim.
Exclusion
- Not being able to fill in the questionnaire in Norwegian language
- Lactose intolerance
- Consumption of probiotics earlier in the pregnancy.
- Intention to move from Trondheim in the next 25 months.
- Pregnant women in risk of eclampsia, or other serious disease that can influence beast-feeding or care for the child.
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
416 Patients enrolled
Trial Details
Trial ID
NCT00159523
Start Date
December 1 2003
End Date
September 1 2007
Last Update
February 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep of Public health and general Practice
Trondheim, Norway, 7489